Acurx Pharmaceuticals LLC (NYSE: ACXP) — Healthcare · Share Price, Chart & Market Data
About: Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.98 (-1.49%)
ACXPAcurx Pharmaceuticals LLC
Loading watchlist status…
Trade ACXP now
Acurx Pharmaceuticals LLC share price
ACXP price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:30 am GMT+0
ACXP price performance
-14.655%
5D
-47.34%
1M
-28.261%
YTD
-76.372%
1Y
ACXP price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:30 am GMT+0
ACXP details
ACXP Market Signals